Pyrole-substituted barbituric derivatives as pharmaceutically significant compounds and intermediates

Pyrrole- and indolecarbaldehydes are condensed with 5-unsubstituted barbituric acids targeting 16 new heterocyclic structures with a prospective pharmacological profile. So 1H-2-pyrrolecarbaldehyde, diethyl 5-formyl-3-methyl-1H-2,4-pyrroledicarboxylate, ethyl 5-formy 1-2,4-dimethyl-l.fl'-3-pyrrolecarboxylate, ethyl 4-formyl-3,5-dimethyl-1H-2-pyrrolecarboxylate, ethyl 4-formyl-2,5-dimethyl-1H-3-pyrrolecarboxylate and l-acetyl-1H-3-indolecarbaldehyde have been condensed in a molar ratio with hexahydro-2,4,6-pyrimidinetrione (barbituric acid) and its 1,3-dimethyl-, 1,3-diphenyl- and 1,3-dicyclohexyl- derivatives. The synthesis takes place in ethanol (or in ethanol/water in the cases of unsubstituted barbituric acid) within several hours at 200 - 600 C in the absence of any catalyst with yields in the range of 70-95%. An insufficient carbonyl activity of N-unsubstituted indole-3-carbaldehyde has been observed and overcome by a preliminary N-acethylation avoiding the inactive vinylene-carboxamide form. In addition to their pharmaceutical significance based on the interaction of two heterocyclic pharmacophores, the condensation products could also be useful as versatile intermediates for further synthesis of new heterocyclic systems. The synthesis of 5-[(4-acetyl-3,5-dimethyl-1H-2-pyrrolyl)(l-acetyl-1H-3-indolyl)methyl] hexahydr= o-2,4,6-pyrimidinetrione (60% in enol-form according to 1H-NMR) by refluxing of [(1-acetyl-1H-3-indolyl) methylene]hexahydro-2,4,6-pyrimidinetrione] and 3-acethyl-2,4-dimethylpyrrole for 6 h in CH3CN illustrates their capability to add C-nucleophiles to the double bound bridging 3 heterocyclic units together. The new 17 products are TLC pure and their structures are proved by 1H-NMR/IR-spectra which interpretation is displayed. (authors)